Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Ballantyne

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Annals of the New York Academy of Sciences|June 17, 1994
Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusionG L Kukielka, K A Youker, H K Hawkins, et al.
Transactions of the Association of American Physicians|January 1, 1993
Molecular evidence for a border zone vulnerable to inflammatory reperfusion injuryK A Youker, H K Hawkins, G L Kukielka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1994
Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survivalC M Ballantyne, E A Mainolfi, J B Young, et al.
Journal of the American College of Cardiology|October 11, 1991
Lipoprotein(a) and apolipoprotein changes after cardiac transplantationJ A Farmer, C M Ballantyne, O H Frazier, et al.
The American Journal of Physiology|December 1, 1995
Myocardial ischemia and reperfusion: a murine modelL H Michael, M L Entman, C J Hartley, et al.
Transplantation Proceedings|August 1, 1987
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin)C M Ballantyne, P H Jones, C Payton-Ross, et al.
Diabetes, Obesity & Metabolism|June 26, 2007
Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities StudyM L Hart Sailors, A R Folsom, C M Ballantyne, et al.
Atherosclerosis|July 17, 1999
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis StudyK Sing, C M Ballantyne, L Ferlic, et al.
Transplantation|October 17, 2001
Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patientsR C Hoogeveen, C M Ballantyne, H J Pownall, et al.
Journal of the American College of Cardiology|May 11, 1992
Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendationsC M Ballantyne, B Radovancevic, J A Farmer, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Annals of the New York Academy of Sciences|June 17, 1994
Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusionG L Kukielka, K A Youker, H K Hawkins, et al.
Transactions of the Association of American Physicians|January 1, 1993
Molecular evidence for a border zone vulnerable to inflammatory reperfusion injuryK A Youker, H K Hawkins, G L Kukielka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1994
Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survivalC M Ballantyne, E A Mainolfi, J B Young, et al.
Journal of the American College of Cardiology|October 11, 1991
Lipoprotein(a) and apolipoprotein changes after cardiac transplantationJ A Farmer, C M Ballantyne, O H Frazier, et al.
The American Journal of Physiology|December 1, 1995
Myocardial ischemia and reperfusion: a murine modelL H Michael, M L Entman, C J Hartley, et al.
Transplantation Proceedings|August 1, 1987
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin)C M Ballantyne, P H Jones, C Payton-Ross, et al.
Diabetes, Obesity & Metabolism|June 26, 2007
Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities StudyM L Hart Sailors, A R Folsom, C M Ballantyne, et al.
Atherosclerosis|July 17, 1999
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis StudyK Sing, C M Ballantyne, L Ferlic, et al.
Transplantation|October 17, 2001
Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patientsR C Hoogeveen, C M Ballantyne, H J Pownall, et al.
Journal of the American College of Cardiology|May 11, 1992
Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendationsC M Ballantyne, B Radovancevic, J A Farmer, et al.
Pageof 12